{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:40:15Z","timestamp":1776469215733,"version":"3.51.2"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T00:00:00Z","timestamp":1548374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Health Research Board","award":["HRA-2013-PHR-685"],"award-info":[{"award-number":["HRA-2013-PHR-685"]}]},{"name":"Health Research Board","award":["HRA-2013-PHR-437"],"award-info":[{"award-number":["HRA-2013-PHR-437"]}]},{"name":"Health Research Board","award":["HRA-2013-PHR-437"],"award-info":[{"award-number":["HRA-2013-PHR-437"]}]},{"name":"Health Research Board","award":["HRA-2013-PHR-685"],"award-info":[{"award-number":["HRA-2013-PHR-685"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210487","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T18:30:30Z","timestamp":1548441030000},"page":"e0210487","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prevalence and treatment of gout among patients with chronic kidney disease in the Irish health system: A national study"],"prefix":"10.1371","volume":"14","author":[{"given":"Elshaeima","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9203-1212","authenticated-orcid":true,"given":"Leonard D.","family":"Browne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9785-949X","authenticated-orcid":true,"given":"Arun","family":"Kumar A. U.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahd","family":"Adeeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander D.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin G.","family":"Stack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,1,25]]},"reference":[{"key":"ref1","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","author":"C-F Kuo","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/qjmed\/hcu057","article-title":"Plasma fibrinogen associates independently with total and cardiovascular mortality among subjects with normal and reduced kidney function in the general population","volume":"107","author":"AG Stack","year":"2014","journal-title":"QJM"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","article-title":"Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study","volume":"131","author":"BF Culleton","year":"1999","journal-title":"Ann Intern Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrrheum.2017.27","article-title":"Risk of premature death in gout unchanged for years","volume":"13","author":"C-F Kuo","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"ref5","article-title":"Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans","author":"JA Singh","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"ref6","article-title":"Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy","author":"NL Edwards","year":"2011","journal-title":"J Med Econ"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e76827","DOI":"10.1371\/journal.pone.0076827","article-title":"Serum Uric Acid and Chronic Kidney Disease: The Role of Hypertension","volume":"8","author":"S Sedaghat","year":"2013","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/ar3806","article-title":"Risk of end-stage renal disease associated with gout: A nationwide population study","volume":"14","author":"KH Yu","year":"2012","journal-title":"Arthritis Res Ther. BioMed Central Ltd"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2215\/CJN.01580210","article-title":"Effect of allopurinol in chronic kidney disease progression and cardiovascular risk","volume":"5","author":"M Goicoechea","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.ajkd.2015.05.017","article-title":"Efficacy of febuxostat for slowing the GFR decline in patients with CKD and asymptomatic hyperuricemia: A 6-month, double-blind, randomized, placebo-controlled trial","volume":"66","author":"D Sircar","year":"2015","journal-title":"Am J Kidney Dis. Elsevier Inc"},{"key":"ref11","article-title":"Effects of uric acid-lowering therapy in patients with chronic kidney disease: A meta-analysis","author":"X Su","year":"2017","journal-title":"PLoS One"},{"key":"ref12","article-title":"Reduced Glomerular Function and Prevalence of Gout: NHANES 2009\u201310","author":"E Krishnan","year":"2012","journal-title":"PLoS One"},{"key":"ref13","article-title":"Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study","author":"J Jing","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A New Equation to Estimate Glomerular Filtration Rate Disclosure of conflicts of interest: We have received confirmation from Drs","volume":"150","author":"AS Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"PE Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"ref16","article-title":"R Foundation for Statistical Computing Vienna Austria","year":"2016"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e50046","DOI":"10.1371\/journal.pone.0050046","article-title":"Reduced glomerular function and prevalence of gout: NHANES 2009\u201310. Steinman TI","volume":"7","author":"E Krishnan","year":"2012","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study","volume":"74","author":"C-F Kuo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13075-015-0522-8","article-title":"Epidemiology and management of gout in Taiwan: a nationwide population study","volume":"17","author":"C-F Kuo","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13075-016-1062-6","article-title":"Incidence and prevalence of gout in Western Sweden","volume":"18","author":"M Dehlin","year":"2016","journal-title":"Arthritis Res Ther. Arthritis Research & Therapy"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3904\/kjim.2016.429","article-title":"Prescription pattern of urate-lowering therapy in Korean gout patients: data from the national health claims database","volume":"33","author":"J Kim","year":"2018","journal-title":"Korean J Intern Med"},{"key":"ref22","article-title":"Chronic kidney disease and the risk of incident gout among middle-aged men: A seven-year prospective observational study","author":"E Krishnan","year":"2013","journal-title":"Arthritis Rheum"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"i51","DOI":"10.1093\/rheumatology\/kex421","article-title":"Education and non-pharmacological approaches for gout","volume":"57","author":"A Abhishek","year":"2018","journal-title":"Rheumatology"},{"key":"ref24","first-page":"1646","article-title":"Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout","volume":"33","author":"N Dalbeth","year":"2006","journal-title":"J Rheumatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1525-139X.2007.00270.x","article-title":"Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events","volume":"20","author":"N Dalbeth","year":"2007","journal-title":"Semin Dial. Wiley\/Blackwell (10.1111)"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/CIRCULATIONAHA.106.657627","article-title":"Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents","volume":"115","author":"ES Ford","year":"2007","journal-title":"Circulation"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1523-1755.2005.00459.x","article-title":"Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan","volume":"68","author":"C-H Tseng","year":"2005","journal-title":"Kidney Int"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/ndt\/gfp740","article-title":"Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: Findings from the Coronary Artery Calcification in Type 1 Diabetes study","volume":"25","author":"DI Jalal","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2337\/db09-0014","article-title":"Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study","volume":"58","author":"P Hovind","year":"2009","journal-title":"Diabetes"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00592-015-0825-x","article-title":"Association of serum uric acid levels with the risk of development or progression of albuminuria among Japanese patients with type 2 diabetes: a prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 10)]","volume":"53","author":"Y Hayashino","year":"2016","journal-title":"Acta Diabetol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1056\/NEJM196107202650302","article-title":"Hyperuricemia in Hyperparathyroidism","volume":"265","author":"DH Mintz","year":"1961","journal-title":"N Engl J Med. Massachusetts Medical Society"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2169\/internalmedicine.31.807","article-title":"Renal handling of urate in two patients with hyperuricemia and primary hyperparathyroidism","volume":"31","author":"I Hisatome","year":"1992","journal-title":"Intern Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/ar3769","article-title":"The independent association between parathyroid hormone levels and hyperuricemia: a national population study","volume":"14","author":"JY Hui","year":"2012","journal-title":"Arthritis Res Ther. BioMed Central Ltd"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00198-011-1776-x","article-title":"Demographic, dietary, and serum factors and parathyroid hormone in the National Health and Nutrition Examination Survey","volume":"23","author":"JM Paik","year":"2012","journal-title":"Osteoporos Int"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2147\/CIA.S90233","article-title":"Significant association between parathyroid hormone and uric acid level in men","author":"K-Y Chin","year":"2015","journal-title":"Clin Interv Aging"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T21:01:21Z","timestamp":1590008481000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210487"}},"subtitle":[],"editor":[{"given":"Petter","family":"Bjornstad","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,25]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210487","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,25]]}}}